Search alternatives:
significant linear » significant clinical (Expand Search), significant gender (Expand Search), significant level (Expand Search)
linear decrease » linear increase (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
significant linear » significant clinical (Expand Search), significant gender (Expand Search), significant level (Expand Search)
linear decrease » linear increase (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
-
281
-
282
-
283
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
284
-
285
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
286
-
287
-
288
-
289
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
290
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
291
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
292
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
293
-
294
-
295
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
296
-
297
-
298
-
299
-
300